Amended Statement of Beneficial Ownership (sc 13d/a)
May 08 2020 - 12:05PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D/A
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Brainstorm Cell Therapeutics Inc.
(Name of Issuer)
Common Stock, $0.00005 par value
(Title of Class of Securities)
10501E201
(CUSIP Number)
Joseph P. Daly
497 Circle Freeway
Cincinnati, Ohio 45246
(513) 943-7100
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
May 07, 2020
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box. [ ]
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7 for other
parties to whom copies are to be sent.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
-----------------------------------------------------------------------------------------------------------
CUSIP No. 10501E201 13D/A
-----------
-----------------------------------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
Joseph P Daly
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
-----------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) [ ]
(b) [ ]
-----------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------------------------------------------
4 SOURCE OF FUNDS (See Instructions)
PF
-----------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) [ ]
-----------------------------------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
-----------------------------------------------------------------------------------------------------------
NUMBER OF SHARES 7 SOLE VOTING POWER
BENEFICIALLY 1,077,500
------------------------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH REPORTING -0-
------------------------------------------------------------------------------
PERSON WITH 9 SOLE DISPOSITIVE POWER
1,077,500
------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,077,500
-----------------------------------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [ ]
-----------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.66%
-----------------------------------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (See Instructions)
IN
-----------------------------------------------------------------------------------------------------------
|
-----------------------------------------------------------------------------------------------------------
CUSIP No. 10501E201 13D/A
-----------
-----------------------------------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
Karina Daly
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
-----------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) [ ]
(b) [X]
-----------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------------------------------------------
4 SOURCE OF FUNDS (See Instructions)
PF
-----------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) [ ]
-----------------------------------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
-----------------------------------------------------------------------------------------------------------
NUMBER OF SHARES 7 SOLE VOTING POWER
BENEFICIALLY 110,000
------------------------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH REPORTING -0-
------------------------------------------------------------------------------
PERSON WITH 9 SOLE DISPOSITIVE POWER
110,000
------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
110,000
-----------------------------------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [ ]
-----------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.37%
-----------------------------------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (See Instructions)
IN
-----------------------------------------------------------------------------------------------------------
|
-----------------------------------------------------------------------------------------------------------
CUSIP No. 10501E201 13D/A
-----------
-----------------------------------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
EssigPR Inc.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
-----------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) [ ]
(b) [X]
-----------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------------------------------------------
4 SOURCE OF FUNDS (See Instructions)
WC
-----------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) [ ]
-----------------------------------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Rincon, PR, USA
-----------------------------------------------------------------------------------------------------------
NUMBER OF SHARES 7 SOLE VOTING POWER
BENEFICIALLY 165,000
------------------------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH REPORTING -0-
------------------------------------------------------------------------------
PERSON WITH 9 SOLE DISPOSITIVE POWER
165,000
------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
165,000
-----------------------------------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [ ]
-----------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.56%
-----------------------------------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (See Instructions)
CO
-----------------------------------------------------------------------------------------------------------
|
ITEM 1. SECURITY AND ISSUER.
The class of equity security to which this statement relates is the
common stock (the "Common Stock"), $0.00005 value per share ("Share"), of
Brainstorm Cell Therapeutics Inc., a Delaware corporation (the "Issuer").
The address of the principal executive offices of the Issuer is
1325 Avenue of Americas, 28th Floor, New York, NY 10019
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
Item 3 is hereby amended to read as follows:
The source of funds used by the Reporting Persons are personal funds of
each such person with respect to the purchases of such person, except
the source of funds used for the purchases by EssigPR, Inc were from
working captial. The Reporting Persons did not borrow any funds to acquire
their respective shares. The following table shows the APPROXIMATE amounts of
funds paid for the Shares by the Reporting Persons.
Joseph P Daly $4,122,028
Karina Daly 454,304
EssigPR, Inc. 673,228
|
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
Item 5 is hereby amended to read as follows:
(a) The Reporting Persons hereby report beneficial ownership, in the manner
hereinafter described, of 1,352,500 shares of the Issuer:
Percentage of
Number Of Outstanding
Shares Held in the Name of Shares Security (1)
Joseph P Daly 1,077,500 3.66%
Karina Daly 110,000 0.37%
EssigPR Inc. 165,000(2) 0.56%
------------ -------
TOTAL 1,352,500 4.59%
|
(1) The foregoing percentages assume that the number of Shares of the Issuer
outstanding,as reported in the Issuer's 10-Q for the quarter ended
March 31, 2020 is 29,440,732 Shares (as of May 4, 2020).
(2) Shares are held by EssigPR,Inc., a C corporation controlled by
Joseph P. Daly
(b) Joseph P. Daly has sole voting and dispositive power over his shares
enumerated in paragraph (a). Karina Daly has sole voting and dispositive
power over her shares enumerated in paragraph (a). EssigPR, Inc. has shared
voting and dispositive power over its shares enumerated in paragraph (a).
(c) Transactions for the 60 days prior to the date of this Schedule 13D :
Person Who Effected the Transaction Transaction Date # of Shares Purchased (Sold) Price per Share
Joseph P. Daly 03/18/2020 100 4.81
Joseph P. Daly 03/19/2020 (20000) 4.73
Joseph P. Daly 03/20/2020 (400) 4.80
Joseph P. Daly 03/20/2020 (2500) 4.77
Joseph P. Daly 03/20/2020 (2076) 4.75
Joseph P. Daly 03/20/2020 100 4.91
Joseph P. Daly 03/23/2020 (1524) 4.77
Joseph P. Daly 03/23/2020 20200 4.83
Joseph P. Daly 03/24/2020 (1000) 4.73
Joseph P. Daly 03/25/2020 (200) 4.79
Joseph P. Daly 03/25/2020 (800) 4.78
Joseph P. Daly 03/25/2020 (300) 4.87
Joseph P. Daly 03/25/2020 (700) 4.86
Joseph P. Daly 03/25/2020 (2000) 4.90
Joseph P. Daly 03/27/2020 (1000) 4.96
Joseph P. Daly 03/31/2020 (1000) 4.91
Joseph P. Daly 04/01/2020 1000 4.48
Joseph P. Daly 04/01/2020 1000 4.44
Joseph P. Daly 04/14/2020 700 5.72
Joseph P. Daly 04/14/2020 400 5.80
Karina Daly 03/16/2020 1000 4.53
Karina Daly 03/16/2020 1000 4.30
Karina Daly 03/18/2020 1000 5.10
Karina Daly 03/18/2020 1000 5.05
Karina Daly 03/18/2020 700 4.94
Karina Daly 03/18/2020 300 4.93
Karina Daly 03/18/2020 1000 4.79
Karina Daly 03/18/2020 1000 4.80
Karina Daly 03/18/2020 300 4.66
Karina Daly 03/18/2020 700 4.65
Karina Daly 04/01/2020 600 4.47
Karina Daly 04/01/2020 900 4.45
Karina Daly 04/01/2020 500 4.44
EssigPR 03/23/2020 700 4.63
EssigPR 03/23/2020 300 4.64
EssigPR 03/23/2020 2000 4.60
EssigPR 03/23/2020 2000 4.65
EssigPR 03/24/2020 2000 4.66
EssigPR 03/24/2020 1000 4.59
EssigPR 03/27/2020 1000 4.90
EssigPR 03/30/2020 2000 4.84
EssigPR 03/30/2020 1900 4.77
EssigPR 03/30/2020 100 4.76
EssigPR 03/30/2020 2000 4.68
EssigPR 03/30/2020 1800 4.56
EssigPR 03/30/2020 200 4.54
EssigPR 03/30/2020 1000 4.58
EssigPR 03/30/2020 700 4.52
EssigPR 03/30/2020 300 4.51
EssigPR 03/30/2020 200 4.49
EssigPR 03/30/2020 800 4.48
EssigPR 03/30/2020 1000 4.41
EssigPR 03/30/2020 700 4.55
EssigPR 03/30/2020 300 4.37
EssigPR 03/31/2020 2000 4.61
EssigPR 03/31/2020 1000 4.55
EssigPR 03/31/2020 1000 4.53
EssigPR 03/31/2020 584 4.47
EssigPR 03/31/2020 900 4.48
EssigPR 03/31/2020 316 4.46
EssigPR 03/31/2020 200 4.44
EssigPR 04/01/2020 1000 4.48
EssigPR 04/01/2020 1000 4.50
EssigPR 04/01/2020 1000 4.41
EssigPR 04/01/2020 300 4.42
EssigPR 04/01/2020 1000 4.47
EssigPR 04/01/2020 700 4.40
EssigPR 04/01/2020 1400 4.39
EssigPR 04/01/2020 300 4.38
EssigPR 04/01/2020 1300 4.37
EssigPR 04/02/2020 1000 4.47
EssigPR 04/02/2020 1000 4.59
EssigPR 04/03/2020 2000 4.69
EssigPR 04/03/2020 1600 4.67
EssigPR 04/03/2020 400 4.66
EssigPR 04/03/2020 300 4.58
EssigPR 04/03/2020 1000 4.59
EssigPR 04/03/2020 1000 4.62
EssigPR 04/06/2020 700 4.78
EssigPR 04/14/2020 400 5.80
|
All transactions were effectuated through open-market purchases
or a result of a counterparty's exercise of a derivatives contract
(d) RIGHT TO RECEIVE OR POWER TO DIRECT: Not applicable.
(e) DATE REPORTING PERSON CEASED TO BE 5% OWNER: 05/07/2020
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: May 08, 2020
/s/ Joseph P Daly
------------------------
Print Name: Joseph P Daly
/s/ Karina Daly
------------------------
Print Name: Karina Daly
|
EssigPR, Inc.
By: /s/ Joseph P Daly
------------------------
Print Name: Joseph P Daly
|
Brainstorm Cell Therapeu... (NASDAQ:BCLI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Brainstorm Cell Therapeu... (NASDAQ:BCLI)
Historical Stock Chart
From Apr 2023 to Apr 2024
